Repligen (RGEN) - P/S ratio

P/S ratio as of November 2026 (TTM): 14.5

According to Repligen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.40. At the end of 2026 the company had a P/S ratio of 10.6.

P/S ratio history for Repligen from 2001 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	10.6	-15.71%
2025	12.5	-2.5%
2024	12.9	-20.43%
2023	16.2	37.72%
2022	11.7	-46.29%
2021	21.8	-23.72%
2020	28.6	60.6%
2019	17.8	49.33%
2018	11.9	6.67%
2017	11.2	12.2%
2016	9.97	-10.61%
2015	11.2	9.27%
2014	10.2	59.86%
2013	6.39	103.04%
2012	3.15	-8.06%
2011	3.42	-37.77%
2010	5.50	-10%
2009	6.11	45.49%
2008	4.20	-59.34%
2007	10.3	60.41%
2006	6.44	-30.4%
2005	9.25	-9.44%
2004	10.2	-46.53%
2003	19.1	66.56%
2002	11.5	-35.84%
2001	17.9

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	2.68	-81.51%	🇺🇸 USA
Thermo Fisher Scientific TMO	5.58	-61.53%	🇺🇸 USA
General Electric GE	6.57	-54.73%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.56	-82.33%	🇺🇸 USA
Sangamo Therapeutics SGMO	0.8872	-93.89%	🇺🇸 USA
Novavax NVAX	3.86	-73.42%	🇺🇸 USA
Neurocrine Biosciences NBIX	4.97	-65.78%	🇺🇸 USA
Bio-Techne TECH	9.39	-35.29%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	3.16	-78.21%	🇺🇸 USA
Charles River Laboratories CRL	4.20	-71.06%	🇺🇸 USA

Company

P/S ratio

P/S ratio differencediff.

Country

Pfizer

PFE

2.68

-81.51%

🇺🇸 USA

Thermo Fisher Scientific

TMO

5.58

-61.53%

🇺🇸 USA

General Electric

6.57

-54.73%

🇺🇸 USA

Bristol-Myers Squibb

BMY

2.56

-82.33%

🇺🇸 USA

Sangamo Therapeutics

SGMO

0.8872

-93.89%

🇺🇸 USA

Novavax

NVAX

3.86

-73.42%

🇺🇸 USA

Neurocrine Biosciences

NBIX

4.97

-65.78%

🇺🇸 USA

Bio-Techne

TECH

9.39

-35.29%

🇺🇸 USA

BioMarin Pharmaceutical

BMRN

3.16

-78.21%

🇺🇸 USA

Charles River Laboratories

CRL

4.20

-71.06%

🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Repligen (RGEN)

P/S ratio as of November 2026 (TTM): 14.5

P/S ratio history for Repligen from 2001 to 2026

PS ratio at the end of each year

P/S ratio for similar companies or competitors

What is the market capitalization of a company?

DISCLAIMER

Contact

Links